Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Diabetes, Obesity & Metabolism|August 10, 2011
Reprogramming gut and pancreas endocrine cells to treat diabetesE Tudurí, T J KiefferHormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 19, 2005
Glucose-dependent insulinotropic polypeptide as a regulator of beta cell function and fateR D Wideman, T J KiefferMinerva Endocrinologica|April 19, 2002
The multifaceted potential of glucagon-like peptide-1 as a therapeutic agentN T Lam, T J KiefferAmerican Journal of Physiology. Endocrinology and Metabolism|January 25, 2000
The adipoinsular axis: effects of leptin on pancreatic beta-cellsT J Kieffer, J F HabenerDiabetologia|December 1, 2010
New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiserY M Cho, T J KiefferProceedings of the National Academy of Sciences of the United States of America|January 20, 1999
Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob miceJ Seufert, T J Kieffer, J F HabenerEndocrinology|October 3, 2000
Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in miceL Baggio, T J Kieffer, D J DruckerBiochemical and Biophysical Research Communications|July 16, 1996
Leptin receptors expressed on pancreatic beta-cellsT J Kieffer, R S Heller, J F HabenerBiochemical and Biophysical Research Communications|June 25, 1996
Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signalingR S Heller, T J Kieffer, J F HabenerEndocrinology|August 1, 1995
Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IVT J Kieffer, C H McIntosh, R A PedersonPageof 5